PHARMA – March 2019

PHARMA - March 2019

Provider: OA National Provider

Contact: Optometry Australia OA Provider, [E] s.hanna@optometry.org.au, [P] 96688550

Learning Objectives

• gain an understanding on the various management options for patients diagnosed with concurrent gl aucoma and ocular surface/dry eye disease
• become more familiar with the various preservative-free therapeutic medication management options for glaucoma patients experiencing issues relating to drop toxicity
• become more familiar with the therapeutic medication management options for acute angle closure glaucoma
• become more familiar with the common mistakes optometrists make in the diagnosis of glaucoma and other eye disease and how this impacts the therapeutic medication management of such patients
• gain an understanding of the reasons why older people are at greater risk of developing glaucoma
• become more familiar with the different types of MIGS devices and how these impact the therapeutic medication management of glaucoma patients
• gain an understanding of the limitations of current glaucoma clinical guidelines, especially in the context of pre-perimetric glaucoma diagnosis and how these can subsequently impact the therapeutic medication management of pre-perimetric glaucoma
• become more familiar with clinical practice guidelines for AMD in order to better manage patients with this disease
• become more familiar with the diagnosis and therapeutic medication management (both topical and oral) of Herpes Simplex Keratitis

Max points awarded: 6.00

Session Information